Biotest expands its clinical development program for trimodulin to patients with community-acquired
EQS-News: Biotest AG / Key word(s): StudyBiotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP) 12.12.2023 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement. PRESS RELEASE Biotest expands its clinical d...